Polaris Partners VII, L.P.

10% owner at Camp4 Therapeutics Corp · on record since Oct 22, 2024
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
10% owner at Metacrine, Inc. · on record since Sep 22, 2020
10% owner at SQZ Biotechnologies Co · on record since Oct 29, 2020

Insider trading activity of Polaris Partners VII, L.P.

Transactions on record: 27; since Jul 7, 2016

Open-market buys: 5; $19M

Open-market sells: 0

Companies traded: 3; last filing Oct 15, 2024

Figures computed from official regulatory filings — .

Companies where Polaris Partners VII, L.P. has traded

Camp4 Therapeutics Corp9 tx · $10M · Oct 15, 2024
SQZ Biotechnologies Co12 tx · $4M · Nov 3, 2020
Syros Pharmaceuticals, Inc.6 tx · $5M · Jul 7, 2016

Track record of Polaris Partners VII, L.P.

Statistical track record

Free account

Open-market buys: 5

Last buy: Oct 15, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of Polaris Partners VII, L.P.

Co-insiders of Polaris Partners VII, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	24,745	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-980,829	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	353,718	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-3,967,234	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	1,250,061	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-14,020,475	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	87,448	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Buy	909,090	11.00 USD	$10M	conv 85ClusterUnusual size+1	SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-277,536	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Buy	16,346	16.00 USD	$261.5K	conv 54ClusterFirst in 12mo	SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-44,120	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-412,608	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Buy	233,654	16.00 USD	$3.7M	conv 54ClusterFirst in 12mo	SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-807,096	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Other	2,315,652	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-28,863	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-24,397	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-56,462	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Other	161,994	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-630,672	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-348,725	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	Other	1,164,486	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	OtherD (derivative)	-83,129	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	Other	22,167	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	OtherD (derivative)	-4,366,825	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	24,745	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-980,829	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	353,718	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-3,967,234	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	1,250,061	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-14,020,475	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Other	87,448	—	n/a (No price was disclosed in the filing)		SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	Buy	909,090	11.00 USD	$10M	conv 85ClusterUnusual size+1	SEC
Camp4 Therapeutics CorpListing on record	Oct 15, 2024	OtherD (derivative)	-277,536	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Buy	16,346	16.00 USD	$261.5K	conv 54ClusterFirst in 12mo	SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-44,120	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-412,608	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Buy	233,654	16.00 USD	$3.7M	conv 54ClusterFirst in 12mo	SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-807,096	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Other	2,315,652	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-28,863	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-24,397	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-56,462	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	Other	161,994	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-630,672	—	n/a (No price was disclosed in the filing)		SEC
SQZ Biotechnologies CoListing on record	Nov 3, 2020	OtherD (derivative)	-348,725	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	Other	1,164,486	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	OtherD (derivative)	-83,129	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	Other	22,167	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 7, 2016	OtherD (derivative)	-4,366,825	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC